Hongguang Nie | Infectious Diseases | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Hongguang Nie
China Medical University

Hongguang Nie
Affiliation China Medical University
Country China
Scopus ID 7103200378
Documents 69
Citations 1143
h-index 17
Subject Area Infectious Diseases
Event Health Scientists Awards
ORCID 0000-0002-9973-6354

The Innovative Research Award recognizes researchers whose scholarly contributions demonstrate sustained impact within their scientific disciplines. Hongguang Nie of China Medical University has established a notable research profile in infectious diseases through peer-reviewed publications, citation influence, and interdisciplinary collaboration. His research activities have contributed to advancing knowledge related to infectious disease mechanisms, clinical outcomes, epidemiology, and healthcare improvement initiatives. The academic record represented through indexed publications and citation metrics reflects continuing engagement with scientific inquiry and evidence-based healthcare research.[1]

Abstract

Hongguang Nie is a researcher affiliated with China Medical University whose scholarly activities are focused primarily on infectious diseases and related biomedical investigations. His publication portfolio demonstrates engagement with epidemiology, disease mechanisms, clinical research, public health applications, and healthcare outcomes. With a documented record of 69 indexed publications, 1,143 citations, and an h-index of 17, his work has achieved measurable visibility within the scientific community. The breadth of his contributions reflects sustained participation in evidence-based research, interdisciplinary collaboration, and the dissemination of findings that support improved understanding of infectious disease challenges and healthcare advancement.[1]

Keywords

Infectious Diseases, Epidemiology, Clinical Research, Public Health, Disease Prevention, Healthcare Outcomes, Biomedical Science, Medical Research, Infection Control, Translational Medicine

Introduction

Research in infectious diseases remains essential for understanding pathogen transmission, disease progression, prevention strategies, and clinical interventions. Hongguang Nie has contributed to this field through scholarly publications that support evidence-based medical knowledge and healthcare improvement. His research activities align with contemporary priorities in disease control, epidemiology, and public health advancement.[2]

Research Profile

Hongguang Nie is affiliated with China Medical University and maintains an active research profile within infectious diseases. His scholarly record includes peer-reviewed publications indexed in international databases, demonstrating ongoing participation in biomedical research. Citation performance and publication productivity indicate sustained engagement with scientific investigation and collaborative academic endeavors.[1]

Research Contributions

The research contributions of Hongguang Nie encompass infectious disease studies, clinical investigations, healthcare outcome assessments, and epidemiological analyses. His publications have supported understanding of disease-related challenges and informed evidence-based approaches in medical science. Collaborative research efforts further demonstrate his commitment to advancing knowledge through multidisciplinary scientific inquiry.[3]

Publications

The publication record associated with Hongguang Nie includes articles published in recognized scientific journals addressing infectious diseases and related healthcare topics. These works contribute to the dissemination of research findings and facilitate scholarly dialogue. Indexed publications and associated citations reflect the visibility and relevance of his research outputs within the academic community.[1]

Research Impact

Research impact can be evaluated through publication influence, citation metrics, and scholarly engagement. With more than one thousand citations and a measurable h-index, Hongguang Nie’s work demonstrates recognition within relevant research communities. His studies contribute to the broader scientific understanding of infectious diseases and support ongoing developments in healthcare research.[1]

Award Suitability

Hongguang Nie’s scholarly achievements, publication record, citation performance, and research focus in infectious diseases align with the objectives of the Innovative Research Award. His demonstrated commitment to scientific investigation and knowledge dissemination supports consideration for recognition within the Health Scientists Awards framework and related academic evaluation processes.[1]

Conclusion

Hongguang Nie has developed a credible academic profile through sustained contributions to infectious disease research. His publication output, citation record, and engagement in scientific collaboration illustrate continued involvement in advancing medical knowledge. These accomplishments support recognition within academic award programs dedicated to research excellence and healthcare innovation.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Hongguang Nie, Author ID 7103200378. Scopus. https://www.scopus.com/authid/detail.uri?authorId=7103200378
  2. Xin, S., Ding, Y., Yu, T., et al. (2025). Mesenchymal Stem Cell-Secreted KGF Ameliorates Acute Lung Injury via the Gab1/ERK/NF-κB Signaling Axis. https://pubmed.ncbi.nlm.nih.gov/40640718/
  3. Li, X., Fu, Y., Yu, T., Song, R., Nie, H., & Ding, Y. (2025). Anti-Oxidant, Anti-Inflammatory and Antiviral Properties of Luteolin Against SARS-CoV-2: Based on Network Pharmacology.     https://pubmed.ncbi.nlm.nih.gov/41011200

Kenjiro Nagai | Infectious Diseases | Research Excellence Award

Published on by Health Scientists

Research Excellence Award

Kenjiro Nagai
Ebina Centro Clinic, Japan

Kenjiro Nagai
Affiliation Ebina Centro Clinic
Country Japan
Scopus ID 56915217000
Documents 20
Citations 585
h-index 12
Subject Area Infectious Diseases
Event Health Scientists Awards
ORCID 0000-0002-7726-7403

Kenjiro Nagai is a researcher affiliated with Ebina Centro Clinic whose scholarly work has contributed to the field of infectious diseases. His publication record, citation performance, and documented research activities demonstrate sustained engagement in clinical and scientific investigations relevant to disease prevention, diagnosis, treatment, and healthcare outcomes. The following article provides a structured overview of his research profile and potential suitability for recognition through the Health Scientists Awards.[1]

Abstract

Kenjiro Nagai has established a research profile centered on infectious diseases and clinically relevant healthcare investigations. His scholarly contributions encompass disease surveillance, patient management strategies, diagnostic evaluation, and evidence-based medical practice. Through a portfolio of peer-reviewed publications and measurable citation influence, his work has supported scientific understanding and practical healthcare applications. The documented research output reflects continuous engagement with contemporary challenges in infectious disease medicine. Bibliometric indicators, including citation performance and h-index, suggest sustained academic visibility. These accomplishments position his research activities as relevant to professional recognition within international scientific and healthcare award frameworks.[1][2]

Keywords

  • Infectious Diseases
  • Clinical Research
  • Disease Prevention
  • Epidemiology
  • Medical Science
  • Patient Care
  • Public Health
  • Health Research

Introduction

The field of infectious diseases remains essential for improving global health outcomes and strengthening healthcare systems. Researchers working within this discipline contribute to understanding disease transmission, treatment approaches, and preventive strategies. Kenjiro Nagai’s scholarly activities align with these objectives through clinically focused investigations and scientific dissemination.[1]

Research Profile

Affiliated with Ebina Centro Clinic in Japan, Kenjiro Nagai has developed a publication record comprising twenty indexed documents. His citation count and h-index indicate continuing academic engagement and recognition within relevant scientific communities focused on infectious diseases and healthcare research.[1]

Research Contributions

His contributions support the advancement of infectious disease knowledge through clinical observations, evidence generation, and publication of findings relevant to patient care. Such efforts contribute to broader scientific understanding and may assist healthcare professionals in informed clinical decision-making processes.[2]

Publications

The documented publication portfolio includes peer-reviewed research articles associated with infectious disease investigations. These works have generated measurable scholarly attention through citations and demonstrate participation in scientific communication, knowledge dissemination, and ongoing engagement with healthcare research topics.[1]

Research Impact

Bibliometric indicators suggest that Kenjiro Nagai’s research has achieved visibility within academic literature. Citation accumulation reflects scholarly use of published findings, while the h-index demonstrates a consistent level of influence across multiple research outputs within the infectious diseases domain.[1]

Award Suitability

Based on available research metrics, publication activity, and subject specialization, Kenjiro Nagai demonstrates characteristics commonly evaluated in scientific recognition programs. His documented contributions to infectious disease research align with the objectives of awards honoring healthcare innovation and scientific advancement.[3]

Conclusion

Kenjiro Nagai’s academic record reflects meaningful engagement in infectious disease research and clinical scholarship. His publication achievements, citation impact, and professional contributions collectively indicate a sustained commitment to advancing medical knowledge and supporting evidence-based healthcare practices.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Kenjiro Nagai, Author ID 56915217000. Scopus.https://www.scopus.com/authid/detail.uri?authorId=56915217000

  2. Nagai, K., Nagai, S., et al. (2025). Report on Successful Treatment of Refractory MAC Lung Disease in Two Elderly Patients with Inhaled Liposomal Amikacin (ALIS) at Half the Standard Dose.

    https://doi.org/10.1016/S1473-3099(20)30154-9

  3. Health Scientists Awards. Award evaluation framework and recognition objectives.https://healthscientists.org/

Simona Hisirová | Medical Microbiology | Best Researcher Award

Published on by Health Scientists

Best Researcher Award

Simona Hisirová,
University of Veterinary Medicine and Pharmacy in Košice, Slovakia

Simona Hisirová
Affiliation University of Veterinary Medicine and Pharmacy in Košice
Country Slovakia
Scopus ID 59755365000
Documents 4
Citations 7
h-index 1
Subject Area Medical Microbiology
Event Health Scientists Awards
Scopus View Profile 

The Best Researcher Award recognition highlights the academic contributions and scholarly activities of Simona Hisirová in the field of medical microbiology and veterinary sciences. Her association with the University of Veterinary Medicine and Pharmacy in Košice reflects continued engagement in microbiological and biomedical research related to health sciences and veterinary medicine.[1] The researcher profile indexed within Scopus demonstrates measurable scholarly output, citation activity, and participation in scientific dissemination through peer-reviewed publications.[2]

Abstract

This academic article presents a structured overview of the professional activities, publication profile, and research influence of Simona Hisirová in the domain of medical microbiology and veterinary health sciences. The article summarizes scholarly achievements associated with indexed publications, citation indicators, institutional affiliation, and scientific engagement relevant to the Health Scientists Awards. The recognition of research excellence within microbiological and biomedical disciplines remains important for promoting interdisciplinary collaboration, veterinary innovation, and evidence-based healthcare development.[1][3]

Keywords

  • Medical Microbiology
  • Nanoparticles
  • Antimicrobial Research
  • Scientific Dissemination
  • Biomedical Research
  • Microbial Studies
  • Academic Publications

Introduction

Research in medical microbiology plays a vital role in public health, veterinary diagnostics, infectious disease surveillance, and biomedical innovation, often involving interdisciplinary studies in microbial characterization, laboratory diagnostics, antimicrobial research, and veterinary healthcare applications.[2] University of Veterinary Medicine and Pharmacy in Košice researcher Simona Hisirová has contributed to these scientific fields through academic and research activities,[4] while recognition through programs such as the Health Scientists Awards encourages continued innovation, publication quality, and scholarly engagement in health sciences.[5]

Research Profile

Simona Hisirová is affiliated with the University of Veterinary Medicine and Pharmacy in Košice, Slovakia, where research activities are connected to veterinary sciences, biomedical investigations, and microbiological analysis. The available Scopus author profile identifies indexed publications and citation metrics relevant to scholarly assessment.[1]

  • Research Area: Medical Microbiology
  • Institutional Affiliation: University of Veterinary Medicine and Pharmacy in Košice
  • Indexed Scopus Documents: 4
  • Citation Count: 7
  • Scopus h-index: 1
  • Country of Academic Activity: Slovakia

Research Contributions

The research contributions of Simona Hisirová are associated with microbiological investigations and veterinary health sciences, supporting understanding of infectious mechanisms, laboratory methodologies, and diagnostic practices.[2] Veterinary microbiology research contributes to disease surveillance, public health protection, antimicrobial stewardship, and biosafety improvements, while scholarly publication activities demonstrate commitment to scientific communication and dissemination of evidence-based findings.[4]

  • Participation in peer-reviewed scientific publication activities.
  • Engagement in microbiological and biomedical research areas.
  • Contribution to veterinary and health science literature.
  • Support for interdisciplinary scientific collaboration.

Publications

The publication profile indexed within Scopus includes scholarly documents related to microbiology and veterinary medicine. Indexed publications provide visibility within the international scientific community and support citation-based academic evaluation.[1]

  1. Research publications indexed in Scopus under Author ID 59755365000.
  2. Scientific articles associated with microbiological and biomedical studies.
  3. Collaborative scholarly outputs connected to veterinary health sciences.

Research Impact

Research impact within the scientific community is commonly assessed through citation activity, publication indexing, collaborative engagement, and relevance to ongoing scientific developments. Citation metrics associated with the Scopus author profile demonstrate recognition of published work within the scholarly literature.[1] The contribution of veterinary microbiology to broader health sciences is increasingly recognized due to its relevance in zoonotic disease management, antimicrobial resistance research, and laboratory diagnostics. Continued participation in scientific publication and dissemination contributes to the advancement of these disciplines.[3]

Award Suitability

The academic profile of Simona Hisirová reflects the objectives of the Health Scientists Awards through active scientific research, peer-reviewed publications, and engagement in health-related disciplines.[5] Recognition of emerging researchers in microbiology and veterinary sciences supports continued scientific inquiry, interdisciplinary collaboration, and scholarly growth. Professional awards also enhance academic visibility, encourage international partnerships, and contribute to the advancement of the global research community. [2]

Conclusion

Simona Hisirová represents an emerging academic contributor within the field of medical microbiology and veterinary health sciences. Through indexed scholarly publications, citation activity, and institutional research involvement, the researcher demonstrates ongoing engagement with scientific investigation and knowledge dissemination. Recognition through the Best Researcher Award framework within the Health Scientists Awards highlights the value of continued contributions to microbiological and biomedical research.[1][5]

References

  1. Elsevier. (n.d.). Scopus author details: Simona Hisirová, Author ID 59755365000. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=59755365000
  2. Hisirová, S., Koscova, J., Király, J., et al. (2025). Resistance Genes and Virulence Factor Genes in Coagulase-Negative and Positive Staphylococci of the Staphylococcus intermedius Group (SIG) Isolated from the Dog Skin. Microorganisms.

    https://www.mdpi.com/journal/microorganisms

  3. Wolaschka, T., Rohaľová, S., Ivana, P., et al. (2025). Formulation of Stimuli-Responsive Gels Containing Silver Complex with Nicotinamide. European Pharmaceutical Journal.

    https://sciendo.com/journal/AFPUC

  4. ResearchGate. (n.d.). Simona Hisirová research profile and publication overview.

    https://www.researchgate.net/profile/Simona-Hisirova
  5. Health Scientists Awards. (n.d.). Award recognition and scientific excellence program.

    Health Scientists Awards
  6. Prevalence of Biofilm-Forming and Antibiotic-Resistant Coagulase-Negative Staphylococci Isolated from Hospitalized Patients in an Orthopedic Clinic. Tatiana Čornejová Szabóová, Gabriela Gregova, Ján Király, et al. (2026). Pathogens.

    https://www.mdpi.com/journal/pathogens

Yang Zhang | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Prof. Dr. Yang Zhang | Clinical Medicine | Best Researcher Award 

Director | Department of Laboratory Medicine Chongqing University | China

Dr. Yang Zhang, Ph.D., currently serves as Director of the Department of Laboratory Medicine at Chongqing University Affiliated Renji Hospital and is an Associate Chief Physician, Postdoctoral Fellow in Clinical Laboratory Diagnostics, and doctoral and master’s supervisor at Chongqing University. She earned her Bachelor of Medicine in Laboratory Medicine (2008), Master of Medicine in Clinical Laboratory Diagnostics (2011), and Ph.D. in Clinical Laboratory Diagnostics (2015) from the Third Military Medical University, complemented by a Ministry of Education-sponsored visiting scholarship at Loma Linda University, USA (2012–2015). Her research centers on precision molecular diagnostics in oncology, with a special focus on POCT rapid diagnostic reagents and spectroscopy-based label-free diagnostic techniques. Dr. Zhang has led multiple high-level research projects, including three funded by the National Natural Science Foundation of China, one by the National Key R&D Program, and numerous provincial and military projects, securing over 6.88 million RMB in funding. She has published more than 40 academic papers as first or corresponding author, with 15 SCI-indexed articles, an H-index of 24, and a single paper cited over 280 times. Her scholarly contributions extend to 12 Chinese invention patents, 1 international PCT patent, and five co-edited scientific monographs, including works on molecular diagnostics and terahertz applications. Dr. Zhang’s achievements have been recognized with numerous honors, such as Chongqing High-Level Young Medical Talent (2022), the “Top Ten Young Scientists in Shapingba District” (2022), First Prize in the Chongqing Association for Science and Technology Innovation (2023), and the National Laboratory Medicine Science and Technology Innovation Award (2021). She also serves as a reviewer for the NSFC and contributes to several national professional committees in laboratory medicine. She has 1044 citations from 43 documents with an h-index of 16.

Profile: Scopus | ORCID 

Publications

1. Zhang, Y. (2020). ENT1 inhibition attenuates apoptosis by activation of cAMP/pCREB/Bcl2 pathway after MCAO in rats. Experimental Neurology, 331, 113362.

2. Zhang, Y. (2020). Identification of immune-related prognostic biomarkers based on the tumor microenvironment in 20 malignant tumor types with poor prognosis. Frontiers in Oncology, 10, 1008.

3. Tian, H., Yuan, C., Liu, Y., Xia, K., Li, M., Xie, F., Chen, Q., Chen, M., Fu, W., & Zhang, Y. (2020, July 28). A sample-to-answer quantification platform for point-of-care testing of circulating microRNAs based on allosteric spherical nanoprobe. Preprint.

4. Zhang, Y. (2020). Evaluation of the reliability of six commercial SERS substrates. Plasmonics, 15(5), 1323–1332.

5. Zhang, Y. (2020). Dataset concerning plasmonic thermal destruction of murine melanoma by gold nanoparticles obtained by green chemistry. Data in Brief, 30, 105370.